Go Pro

Versigent (NYSE:VGNT) Director Kevin Clark Sells 74,130 Shares of Stock

Versigent logo with background
Image from MarketBeat Media, LLC.

Key Points

  • Director Kevin Clark sold 74,130 Versigent shares at an average price of $45.67, generating approximately $3.39 million; his remaining stake fell 37.26% to 124,849 shares.
  • Versigent reported quarterly adjusted earnings of $1.92 per share and revenue of $2.44 billion, beating analyst estimates of $1.58 per share and $2.29 billion, respectively.
  • The company declared a quarterly dividend of $0.13 per share, or $0.52 annualized, representing a 1.1% yield; analysts maintain a “Moderate Buy” consensus with an average price target of $54.
  • Five stocks we like better than Versigent.

Versigent (NYSE:VGNT - Get Free Report) Director Kevin Clark sold 74,130 shares of Versigent stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $45.67, for a total transaction of $3,385,517.10. Following the completion of the sale, the director owned 124,849 shares in the company, valued at approximately $5,701,853.83. This represents a 37.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Versigent Stock Performance

Shares of VGNT traded up $0.71 during midday trading on Thursday, hitting $46.45. 470,596 shares of the company traded hands, compared to its average volume of 1,777,686. The firm has a 50 day simple moving average of $44.16. Versigent has a 52 week low of $26.34 and a 52 week high of $50.88. The stock has a market cap of $3.29 billion and a PE ratio of 24.19. The company has a debt-to-equity ratio of 7.29, a quick ratio of 1.09 and a current ratio of 1.40.

Versigent (NYSE:VGNT - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $1.92 earnings per share for the quarter, beating analysts' consensus estimates of $1.58 by $0.34. The firm had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.29 billion. Sell-side analysts predict that Versigent will post 7.23 earnings per share for the current fiscal year.

Versigent Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 18th. Shareholders of record on Friday, September 4th will be paid a $0.13 dividend. The ex-dividend date of this dividend is Friday, September 4th. This represents a $0.52 dividend on an annualized basis and a yield of 1.1%.

Institutional Investors Weigh In On Versigent

Institutional investors have recently made changes to their positions in the company. Wellington Management Group LLP bought a new stake in Versigent in the second quarter worth about $940,000. Ancora Advisors LLC purchased a new position in shares of Versigent during the second quarter valued at approximately $4,197,000. Kintegral Advisory LLC bought a new position in shares of Versigent during the second quarter valued at approximately $224,000. Nan Shan Life Insurance Co. Ltd. bought a new position in shares of Versigent during the second quarter valued at approximately $5,400,000. Finally, Raiffeisen Bank International AG purchased a new stake in shares of Versigent in the second quarter worth approximately $1,182,000.

Analyst Ratings Changes

A number of research firms have recently commented on VGNT. Argus increased their target price on Versigent from $50.00 to $54.00 and gave the company a "buy" rating in a research report on Thursday, August 13th. Weiss Ratings initiated coverage on shares of Versigent in a research report on Wednesday, August 5th. They issued a "hold (c)" rating on the stock. Fox Advisors lowered shares of Versigent from an "overweight" rating to an "equal weight" rating in a research report on Wednesday, August 5th. TD Cowen lifted their price objective on shares of Versigent from $49.00 to $58.00 and gave the stock a "buy" rating in a research note on Wednesday, August 5th. Finally, UBS Group reduced their target price on shares of Versigent from $58.00 to $55.00 and set a "buy" rating on the stock in a report on Thursday, July 9th. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $54.00.

View Our Latest Research Report on VGNT

About Versigent

(Get Free Report)

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Versigent Right Now?

Before you consider Versigent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Versigent wasn't on the list.

While Versigent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines